Search for: "-JAD ELI LILLY AND COMPANY v. ACTAVIS ELIZABETH LLC" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Lilly Wins Appeal Protecting Attention-Deficit Disorder Drug Patent
1 Aug 2011, 8:19 am
Actavis Elizabeth LLC et al, Case No. 2010-1500 in the Court of Appeals for the Federal Circuit, decided July 29, 2011. [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Walking the Enablement/Non-obviousness Tightrope
14 Feb 2010, 4:20 pm by Aaron Barkoff
Cir. 2009) Eli Lilly & Co. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Drug Label Established Intent to Induce Although the Drug was Prescribed for Noninfringing Use and the Label was Required by the FDA
8 Jan 2010, 5:17 am by The Docket Navigator
"Eli Lilly and Company v. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Reconsidering Divided Infringement
12 Jan 2010, 7:26 am by Dennis Crouch
See, for example, Eli Lilly and Co. v. [read post]
Patently-O - http://www.patentlyo.com/patent/
Pharma & Biotech Global Week in Review 18 August 2010 from IP Think Tank
18 Aug 2010, 12:19 am by Kelly
(Patent Baristas) Strattera (Atomoxetine) – US: District Court rules against Lilly regarding Strattera patent: Eli Lilly v Actavis Elizabeth (GenericsWeb) Vigamox (Moxifloxacin) – US: Alcon denied permanent injunction against Teva in Vigamox litigation (Patent Docs) [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Drug Label Encouraging Infringing Use Shows Intent to Induce (Even if Prescribed for Noninfringing Use)
14 Jan 2010, 11:09 am by Guest Barista
Eli Lilly and Company v. [read post]
Patent Baristas - http://www.patentbaristas.com
Pharma & Biotech Global Week in Review 1 September 2010 from IP Think Tank
31 Aug 2010, 10:01 pm by Kelly
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of generic… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
When is the use of a product a “substantial noninfringing use” for purposes of Section 271(c)?
11 Dec 2023, 7:43 am by Holman
Actavis Elizabeth LLC). [read post]
Patently-O - https://patentlyo.com
Pharma & Biotech Global Week in Review 17 August 2011 from IP Think Tank
16 Aug 2011, 11:35 pm by Marie Louise
Novozymes – DC The Hague v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 13 January 2010 from IP Think Tank
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle)   Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 17 Feb 2010 from IP Think Tank
17 Feb 2010, 5:10 am
Actavis Elizabeth LLC, et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog